Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 04, 2015 11:04 PM ET

Biotechnology

Company Overview of Afferent Pharmaceuticals, Inc.

Key Executives for Afferent Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Anthony P. Ford Ph.D.No RelationshipsCo-Founder and Chief Scientific Officer--
Michael M. Kitt M.D.8 RelationshipsChief Medical Officer64
Peter G. Butera No RelationshipsVice President of Clinical Operations--

Afferent Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Kevin P. Starr 88 RelationshipsThird Rock Ventures, LLC51
Arthur M. Pappas MBA 123 RelationshipsPappas Ventures66
Liam Ratcliffe M.D., Ph.D. 25 RelationshipsNew Leaf Venture Partners, L.L.C.51
Jesse I. Treu Ph.D. 107 RelationshipsDomain Associates, L.L.C.67
Steven B. Abramson M.D. 31 RelationshipsAfferent Pharmaceuticals, Inc.--
View All Board Members

Afferent Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
396.2K
Bonus
248.4K
Total Short Term Compensation
489.0K
Total Value of Options
33.1M
Compensation as of Fiscal Year
Afferent Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

SCA Announces Resignation of Rolf Börjesson as Member of the Board of Directors
May 04, 2015 5:57 AM ET
Energizer Holdings Inc. Announce Composition of New Boards of Directors
April 27, 2015 9:00 PM ET
Anders Nyrén to Leave His Assignment as Member of SCA Board of Directors as of April 30, 2015
April 27, 2015 5:58 AM ET
The Clorox Company Announces Retirement of Daniel Boggan as Directors, Effective May 13, 2015
April 24, 2015 9:00 PM ET
Worldwise Promotes Jeff Leh to Vice President of Sales
April 22, 2015 10:15 AM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Afferent Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.